References
- Mahungu TW, Rodger AJ, Johnson MA. HIV as a chronic disease. Clin Med. 2009;9(2):125–128.
- Marcus JL, Leyden WA, Alexeeff SE, et al. Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000-2016. JAMA Netw Open. 2020;3(6):e207954.
- Astuti N, Maggiolo F. Single-tablet regimens in HIV therapy. Infect Dis Ther. 2014;3(1):1–17.
- McCann NC, Horn TH, Hyle EP, et al. HIV antiretroviral therapy costs in the United States, 2012-2018. JAMA Intern Med. 2020;180(4):601–603.
- Ritchwood TD, Bishu KG, Egede LE. Trends in healthcare expenditure among people living with HIV/AIDS in the United States: evidence from 10 Years of nationally representative data. Int J Equity Health. 2017;16(1):188.
- GBD 2017 HIV collaborators. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the global burden of diseases, injuries, and risk factors study 2017. Lancet HIV. 2019;6(12):e831–e859.
- Hellenic Public Health Organization. HIV λοίμωξη: προκαταρκτικά επιδημιολογικά δεδομένα, Οκτώβριος 2019 [HIV infection: preliminary epidemiological data, October 2019]. Hellenic Public Health Organization, Οffice of HIV infection and STDs; 2019. Greek. [retracted material]
- European Centre for Disease Prevention and Control, World Health Organization. HIV/AIDS surveillance in Europe 2020. 2019 data. Sweden: ECDC/Denmark: WHO. 2020.
- Hellenic Association of Pharmaceutical Companies. The pharmaceutical market in Greece. Facts & figures 2019. Athens: Hellenic Association of Pharmaceutical Companies; 2020. [cited 2021 May 21]. Available from: https://sfee.gr/wp-content/uploads/2020/07/F-F-2019-ENG-new.pdf
- European AIDS Clinical Society. Clinical management and treatment of HIV infected adults in Europe. Guidelines. Version 5. November 2009. Paris: European AIDS Clinical Society; 2009. [cited 2021 May 21]. Available from: https://www.eacsociety.org/files/2009_eacsguidelines-v5-english.pdf
- Lundgren JD, Babiker AG, Gordin F, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795–807.
- World Health Organization. Guideline on when to start antiretroviral therapy and on Pre-Exposure prophylaxis for HIV. Switzerland: World Health Organization; 2015. [cited 2021 May 21]. Available from: https://apps.who.int/iris/bitstream/handle/10665/186275/9789241509565_eng.pdf.;jsessionid=BEF1EB0E516EC5CFD1ACD4BD98B0601C?sequence=1
- European Centre for Disease Prevention and Control. Joint technical mission: HIV in Greece 28–29 May 2012. Stockholm; 2013.
- Hellenic Centre for Disease Control and Prevention. HIV/AIDS Surveillance Report in Greece, 31-10-2010 (Issue 25). Athens 2010. Hellenic Centre for Disease Control and Prevention, 2010. [cited 2021 May 21]. Available from: https://eody.gov.gr/wp-content/uploads/2018/12/epidimiologiko-2010.pdf
- Hellenic Centre for Disease Control and Prevention. HIV λοίμωξη: νεότερα επιδημιολογικά δεδομένα, Οκτώβριος 2015 [HIV infection: latest epidemiological data, October 2015]. Hellenic Centre for Disease Control and Prevention, Office for HIV and STDs; 2015. Greek. [retracted material]
- Hellenic Ministry of Health. Medication Price Bulletin. [cited 2021 May 21]. Available from: https://www.sfee.gr/enieo-deltio-timon-farmakon-05-2009/
- Hellenic Ministry of Health. Medication Price Bulletin. [cited 2021 May 21]. Available from: https://www.sfee.gr/deltio-timon-farmakon-01-2010/
- Hellenic Ministry of Health. Medication Price Bulletin. [cited 2021 May 21]. Available from: https://www.sfee.gr/deltio-timon-farmakon-04-2010/
- Helenic Ministry of Health. Medication Price Bulletin. Available from: https://www.moh.gov.gr/articles/times-farmakwn/deltia-timwn/2681-deltio-timwn-farmakwn-anthrwpinhs-xrhshs-12-8-2014. Αccessed May 21, 2021.
- Hellenic Ministry of Health. Medication Price Bulletin. [cited 2021 May 21]. Available from: https://www.moh.gov.gr/articles/times-farmakwn/deltia-timwn/5546-deltio-timwn-farmakwn-anthrwpinhs-xrhshs-maioy-2018-11062018
- The President of the Hellenic Republic. ΦΕΚ Α 74/19.05.2017, Νόμος Υπ’ αριθμ. 4472 [Government Gazette Issue A 74/19.05.2017, Law Νο. 4472]; Athens: National Printing Office. Greek. [cited 2021 May 21]. Available from: http://www.et.gr/idocs-nph/search/pdfViewerForm.html?args=5C7QrtC22wEsrjP0JAlxBXdtvSoClrL8R5ab1UmX_HjtIl9LGdkF53UIxsx942CdyqxSQYNuqAGCF0IfB9HI6qSYtMQEkEHLwnFqmgJSA5WIsluV-nRwO1oKqSe4BlOTSpEWYhszF8P8UqWb_zFijAs3sW_wqEaAtER_qx6Ix3u0EXkm1g8CgA3p_dBREYUS
- Hellenic Ministry of Health. ΦΕΚ Β 4274/22.11.2019: Αριθμ. Δ3(α)οικ.82331 [Government Gazette Issue Β 4274/22.11.2019: Ministerial Decision Δ3(α)οικ.82331]; Athens: National Printing Office. Greek. [cited 2021 May 21]. Available from: https://www.moh.gov.gr/articles/times-farmakwn/ypoyrgikes-apofaseis-agoranomikes-diatakseis/5556-diatakseis-timologhshs-farmakwn-g5-a-oik-90552-fek-3890-b-2016?fdl=15704
- The President of the Hellenic Republic. ΦΕΚ Α 1/05.01.1999, Νόμος Υπ’ αριθ. 2676 [government gazette issue a 1/05.01.1999, law 2676]. Athens: National Printing Office. [cited 2021 October 15]. Available from: https://www.taxheaven.gr/law/2676/1999
- IQVIA Institute for Human Data Science. HIV Panel Database. HIV Audit, December 2019.
- Mostardt S, Hanhoff N, Wasem J, et al. Cost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGNÄ K3A study. Eur J Health Econ. 2013;14(5):799–808.
- Coelho LE, Ribeiro SR, Veloso VG, et al. Hospitalization rates, length of stay and in-hospital mortality in a cohort of HIV infected patients from Rio De Janeiro, Brazil. Brazilian J Infect Dis. 2017;21(2):190–195.
- Mahlab-Guri K, Asher I, Bezalel-Rosenberg S, et al. Hospitalizations of HIV patients in a major israeli HIV/AIDS center during the years 2000 to 2012. Medicine. 2017;96(18):e6812.
- Taramasso L, Demma F, Bitonti R, et al. How has the cost of antiretroviral therapy changed over the years? A database analysis in Italy. BMC Health Serv Res. 2018;18(1):691.
- Bellino S, Borghetti A, Lombardi F, et al. Trends of hospitalisations rates in a cohort of HIV-infected persons followed in an Italian hospital from 1998 to 2016. Epidemiol Infect. 2019;147:e89.
- Johnson TL, Toliver JC, Mao L, et al. Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study. BMC Infect Dis. 2014;14(1):217.
- Brennan-Ing M, Seidel L, Rodgers L, et al. The impact of comprehensive case management on HIV client Outcomes. PLOS One. 2016;11(2):e0148865.
- Krentz H, Vu Q, Gill M. Updated direct costs of medical care for HIV‐infected patients within a regional population from 2006 to 2017. HIV Med. 2020;21(5):289–298.
- Greek Diagnostic Related Groups System. [cited 2021 May 21]. Available from: http://kenicd.e-healthnet.gr/
- Hellenic Ministry of Health, Hellenic Ministry of Finance. ΦΕΚ Β 1181/08.05.2014: Αριθμ Υ9α/οικ 37139 [Government Gazette Issue Β 1181/08.05.2014; Joint Ministerial Decision Υ9α/οικ 37139]; Athens: National Printing Office. Greek. [cited 2021 May 21]. Available from: http://www.dsanet.gr/Epikairothta/Nomothesia/ya%20%CE%A59%CE%B1_14.htm
- European AIDS Clinical Society. Guidelines for the clinical management and treatment of HIV infected adults in Europe. Paris: European AIDS Clinical Society; 2007. [cited 2021 May 21]. Available from: https://www.eacsociety.org/files/2007_eacsguidelines-v1-english_oct_madrid_1.pdf
- European AIDS Clinical Society. Guidelines. Version 6- October 2011. Paris: European AIDS Clinical Society; 2011. [cited 2021 May 21]. Available from: https://www.eacsociety.org/files/2011_eacsguidelines-v6.0-english_oct.pdf
- Hellenic Centre for Disease Control and Prevention. Κατευθυντήριες οδηγίες χορήγησης αντιρετροϊκής αγωγής και θεραπείας καιροσκοπικών λοιμώξεων σε ενήλικες και εφήβους με HIV λοίμωξη [guidelines for the administration of antiretroviral treatment and treatment of opportunistic infections in adults and adolescents with HIV infection]. Athens: Hellenic Centre for Disease Control and Prevention; 2018. Greek. [cited 2021 May 21]. Available from: https://eody.gov.gr/wp-content/uploads/2018/12/antiretroiki-agogi-11-05-2018.pdf
- National Organization for the Provision of Health Services. Κατηγορίες ιατρικών πράξεων [Categories of Medical Procedures]. Greek. [cited 2021 May 21]. Available from: https://eopyyfiles.blob.core.windows.net/eopyysite/ServiceCategories/038dc470-fbe3-409b-bdd7-7efb3b37f984.pdf
- National Public Health Organization. HIV/AIDS surveillance report in Greece, 31-12-2019 (issue 34). Athens: National Public Health Organization; 2020. [cited 2021 May 21]. Available from: https://eody.gov.gr/wp-content/uploads/2018/12/epidimiologiko-deltio-hiv-2019.pdf
- Vourli G, Noori T, Pharris A, et al. Human immunodeficiency virus continuum of care in 11 European Union Countries at the end of 2016 overall and by key population: have we made progress? Clin Infect Dis. 2020;71(11):2905–2916.
- IQVIA Institute for Human Data Science. Medicine use and spending in the U.S. A review of 2018 and outlook to 2023. USA: IQVIA; 2019. Available from: https://www.iqvia.com/insights/the-iqvia-institute/reports/medicine-use-and-spending-in-the-us-a-review-of-2018-and-outlook-to-2023
- Quiros-Roldan E, Magoni M, Raffetti E, et al. The burden of chronic diseases and cost-of-care in subjects with HIV infection in a health district of Northern Italy over a 12-year period compared to that of the general population. BMC Public Health. 2016;16(1):1146.
- Forsythe SS, McGreevey W, Whiteside A, et al. Twenty years of antiretroviral therapy for people living with HIV: global costs, health achievements, economic Benefits. Health Aff. 2019;38(7):1163–1172.
- Oguntibeju OO. Quality of life of people living with HIV and AIDS and antiretroviral therapy. HIV AIDS. 2012;4:117–124.
- Pimentel GS, Ceccato MDGB, Costa JO, et al. Quality of life in individuals initiating antiretroviral therapy: a cohort study. Rev Saude Publica. 2020;54:146.
- Colin X, Lafuma A, Costagliola D, et al. The cost of managing HIV infection in highly treatment-experienced, HIV-infected adults in France. Pharmacoeconomics. 2010;28 Suppl 1:59–68.
- Farnham P, Gopalappa C, Sansom S, et al. Updates of lifetime costs of care and quality-of-life estimates for HIV-infected persons in the United States: late versus early diagnosis and entry into care. J Acquir Immune Defic Syndr. 2013;64(2):183–189.
- Pantazis N, Chini M, Antoniadou A, et al. The HIV patient profile in 2013 and 2003: Results from the Greek AMACS cohort. PLOS One. 2018;13(9):e0203601.
- Pelchen-Matthews A, Ryom L, Borges ÁH, et al. Aging and the evolution of comorbidities among HIV-positive individuals in a European Cohort. AIDS. 2018;32(16):2405–2416.
- Dunn K, Lafeuille MH, Jiao X, et al. Risk factors, health care resource utilization, and costs associated with nonadherence to antiretrovirals in Medicaid-Insured patients with HIV. JMCP. 2018;24(10):1040–1051.
- Kangethe A, Polson M, Lord TC, et al. Real-World health plan data analysis: key trends in medication adherence and overall costs in patients with HIV. JMCP. 2019;25(1):88–93.